1 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Thrombomodulin alfa
Thrombomodulin alfa
💬
|
Thrombomodulin Alfa
| 1件: 85 85 💬 |
2 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Dabigatran etexilate
Dabigatran etexilate
💬
|
Dabigatran etexilate
| 2件: 51 51, 75 💬 |
3 |
F2
💬
| 8件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Coronavirus disease - COVID-19, Pathways in cancer | Dabigatran
Dabigatran
💬
|
Dabigatran
| 5件: 51 51, 75, 85, 91, 124 💬 |
4 |
F8
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Desmopressin
Desmopressin
💬
|
Desmopressin
| 6件: 6 6, 64, 72, 75, 225, 288 💬 |
5 |
F9
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬
|
Emicizumab
| 1件: 288 288 💬 |
6 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Apixaban
Apixaban
💬
|
Apixaban
| 1件: 222 222 💬 |
7 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Rivaroxaban
Rivaroxaban
💬
|
Rivaroxaban
| 4件: 46 46, 49, 91, 210 💬 |
8 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Edoxaban
Edoxaban
💬
|
Edoxaban
| 2件: 46 46, 88 💬 |
9 |
F10
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Emicizumab
Emicizumab
💬
|
Emicizumab
| 1件: 288 288 💬 |
10 |
FCER1A
💬
| 4件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Fc epsilon RI signaling pathway, Asthma | Omalizumab
Omalizumab
💬
|
Omalizumab
| 7件: 46 46, 53, 65, 98, 162, 226, 299 💬 |
11 |
FCGRT
💬
| - | Nipocalimab
Nipocalimab
💬
|
Nipocalimab
| 6件: 11 11, 14, 46, 49, 53, 61 💬 |
12 |
FCGRT
💬
| - | Efgartigimod alfa
Efgartigimod alfa
💬
|
Efgartigimod alfa
| 6件: 11 11, 14, 35, 53, 63, 162 💬 |
13 |
FCGRT
💬
| - | Batoclimab
Batoclimab
💬
|
Batoclimab
| 2件: 11 11, 14 💬 |
14 |
FCGRT
💬
| - | Orilanolimab
Orilanolimab
💬
|
Orilanolimab
| 1件: 61 61 💬 |
15 |
FCGRT
💬
| - | Rozanolixizumab
Rozanolixizumab
💬
|
Rozanolixizumab
| 3件: 11 11, 14, 63 💬 |
16 |
FDPS
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | Zoledronic acid
Zoledronic acid
💬
|
Zoledronic acid
| 13件: 5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 💬 |
17 |
FDPS
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | Alendronic acid
Alendronic acid
💬
|
Alendronic acid
| 7件: 19 19, 41, 46, 50, 271, 274, 299 💬 |
18 |
FDPS
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | Pamidronic acid
Pamidronic acid
💬
|
Pamidronic acid
| 3件: 270 270, 271, 274 💬 |
19 |
FDPS
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | Risedronic acid
Risedronic acid
💬
|
Risedronic acid
| 9件: 46 46, 50, 66, 93, 95, 96, 107, 113, 274 💬 |
20 |
FDPS
💬
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, Influenza A, Human T-cell leukemia virus 1 infection | Zoledronic acid
Zoledronic acid
💬
|
Zoledronic acid
| 13件: 5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 💬 |
21 |
FGFR1
💬
| 16件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Breast cancer, Central carbon metabolism in cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 💬 |
22 |
FGFR1
💬
| 16件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Breast cancer, Central carbon metabolism in cancer | Infigratinib
Infigratinib
💬
|
Infigratinib
| 1件: 276 276 💬 |
23 |
FGFR3
💬
| 13件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, MicroRNAs in cancer, Bladder cancer, Central carbon metabolism in cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 💬 |
24 |
FGFR3
💬
| 13件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, MicroRNAs in cancer, Bladder cancer, Central carbon metabolism in cancer | Infigratinib
Infigratinib
💬
|
Infigratinib
| 1件: 276 276 💬 |
25 |
FGFR2
💬
| 13件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Gastric cancer, Central carbon metabolism in cancer | Palifermin
Palifermin
💬
|
Palifermin
| 5件: 13 13, 36, 38, 39, 65 💬 |
26 |
FGFR2
💬
| 13件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Gastric cancer, Central carbon metabolism in cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 💬 |
27 |
FGFR2
💬
| 13件: EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Gastric cancer, Central carbon metabolism in cancer | Infigratinib
Infigratinib
💬
|
Infigratinib
| 1件: 276 276 💬 |
28 |
FLT1
💬
| 9件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | Axitinib
Axitinib
💬
|
Axitinib
| 1件: 34 34 💬 |
29 |
FLT1
💬
| 9件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | Sunitinib
Sunitinib
💬
|
Sunitinib
| 2件: 28 28, 34 💬 |
30 |
FLT1
💬
| 9件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | Cediranib
Cediranib
💬
|
Cediranib
| 1件: 34 34 💬 |
31 |
FLT1
💬
| 9件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis | Nintedanib
Nintedanib
💬
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 💬 |
32 |
FLT3
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer | Sorafenib
Sorafenib
💬
|
Sorafenib
| 2件: 34 34, 86 💬 |
33 |
FLT3
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer | Sunitinib
Sunitinib
💬
|
Sunitinib
| 2件: 28 28, 34 💬 |
34 |
FLT3
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer | Pexidartinib
Pexidartinib
💬
|
Pexidartinib
| 1件: 34 34 💬 |
35 |
FLT4
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | Axitinib
Axitinib
💬
|
Axitinib
| 1件: 34 34 💬 |
36 |
FLT4
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | Sorafenib
Sorafenib
💬
|
Sorafenib
| 2件: 34 34, 86 💬 |
37 |
FLT4
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | Sunitinib
Sunitinib
💬
|
Sunitinib
| 2件: 28 28, 34 💬 |
38 |
FLT4
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | Cediranib
Cediranib
💬
|
Cediranib
| 1件: 34 34 💬 |
39 |
FLT4
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | Nintedanib
Nintedanib
💬
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 💬 |
40 |
FLT4
💬
| 8件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer, Breast cancer | Tesevatinib
Tesevatinib
💬
|
Tesevatinib
| 1件: 67 67 💬 |
41 |
FNTA
💬
| 1件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis | Tipifarnib
Tipifarnib
💬
|
Tipifarnib
| 1件: 34 34 💬 |
42 |
FNTA
💬
| 1件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis | Lonafarnib
Lonafarnib
💬
|
Lonafarnib
| 2件: 113 113, 333 💬 |
43 |
FNTB
💬
| 1件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis | Tipifarnib
Tipifarnib
💬
|
Tipifarnib
| 1件: 34 34 💬 |
44 |
FNTB
💬
| 1件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis | Lonafarnib
Lonafarnib
💬
|
Lonafarnib
| 2件: 113 113, 333 💬 |
45 |
FYN
💬
| 14件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Axon guidance, Osteoclast differentiation, Focal adhesion, Adherens junction, Platelet activation, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Cholinergic synapse, Prion disease, Pathogenic Escherichia coli infection, Viral myocarditis | Dasatinib
Dasatinib
💬
|
Dasatinib
| 2件: 51 51, 85 💬 |
46 |
FYN
💬
| 14件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Axon guidance, Osteoclast differentiation, Focal adhesion, Adherens junction, Platelet activation, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Cholinergic synapse, Prion disease, Pathogenic Escherichia coli infection, Viral myocarditis | Dasatinib
Dasatinib
💬
|
Dasatinib
| 2件: 51 51, 85 💬 |
47 |
FGF23
💬
| 11件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Melanoma, Breast cancer, Gastric cancer | Burosumab
Burosumab
💬
|
Burosumab
| 1件: 238 238 💬 |